What's next for Medtronic's RDN program after FDA approval

Medtronic RDN leader Jason Weidman discusses plans for Symplicity Spyral's commercialization, manufacturing and postmarket studies.

Related Keywords

Ireland ,Jason Weidman ,Medtronic ,Recor Medical ,How Recor Medical ,Symplicity Spyral ,Medical Design ,